T11248 |
Evogliptin tartrate
|
1222102-51-3
|
98%
|
|
Evogliptin tartrate has potential for anti-atherosclerosis therapy that targets arterial inflammation. Evogliptin tartrate is a potent, orally bioavailable and s...
|
T6203 |
Saxagliptin
|
361442-04-8
|
99.95%
|
|
Saxagliptin (BMS-477118) is a selective and reversible DPP4 inhibitor with IC50 of 26 nM.
|
T4042 |
Talabostat mesylate
|
150080-09-4
|
99.91%
|
|
Talabostat mesylate (PT100) is an orally active, selective inhibitor of dipeptidyl peptidases IV (DPP4, IC50: 0.18 nM), including tumor-associated fibroblast act...
|
T0178 |
Saxagliptin hydrate
|
945667-22-1
|
99.8%
|
|
Saxagliptin hydrate (Onglyza hydrate) is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM).
|
T6192 |
Alogliptin
|
850649-61-5
|
99.77%
|
|
Alogliptin (SYR-322)(SYR-322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10, 000-fold selectivity over DPP-8 and DPP-9....
|
T23358 |
Sitagliptin phosphate
|
654671-78-0
|
99.72%
|
|
Sitagliptin phosphate (MK-0431 phosphate) is a dipeptidyl peptidase-4 (DPP4) inhibitor.
|
T2316 |
Omarigliptin
|
1226781-44-7
|
99.70%
|
|
Omarigliptin (MK-3102) has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency.
|
T0242L |
Sitagliptin phosphate monohydrate
|
654671-77-9
|
99.65%
|
|
Sitagliptin phosphate monohydrate (MK-0431 phosphate monohydrate) is a potent inhibitor of DPP-IV with IC50 of 19 nM in Caco-2 cell extracts.
|
T15079 |
DBPR108
|
1186426-66-3
|
99.65%
|
|
DBPR108 is an orally bioavailable dipeptide-derived DPP4 inhibitor (IC50: 15 nM) and it has no inhibition on DDP8 and DPP9.
|
T1581 |
Picolamine
|
3731-52-0
|
99.64%
|
|
Picolamine acts as a potential inhibitor of DPP-4.
|
T0242 |
Sitagliptin
|
486460-32-6
|
99.4%
|
|
Sitagliptin (MK0431), a new oral hypoglycemic (anti-diabetic drug), is a new dipeptidyl peptidase-4 (DPP-4) inhibitor. This enzyme-inhibiting drug is used either...
|
T68053 |
Denagliptin
|
483369-58-0
|
99.37%
|
|
Denagliptin is a small molecule dipeptidyl peptidase IV (DPP-4) inhibitor for the treatment of endocrine Ü metabolic diseases and can be used in the study of typ...
|
T25340 |
Diprotin A
|
90614-48-5
|
99.29%
|
|
Diprotin A (Ile-Pro-Ile) (Ile-Pro-Ile) is a dipeptidyl peptidase IV (DPP-IV) inhibitor.
|
T0191 |
Linagliptin
|
668270-12-0
|
99.15%
|
|
Linagliptin (BI 1356) is a potent, orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity.
|
T12710 |
Retagliptin Phosphate
|
1256756-88-3
|
98.97%
|
|
Retagliptin Phosphate (SP 2086) is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.
|
T6237 |
Trelagliptin
|
865759-25-7
|
98.94%
|
|
Trelagliptin (SYR-472) is a highly specific and long-acting DPP-4 inhibitor.
|
T11526 |
DPP-IV-IN-2
|
136259-18-2
|
98.93%
|
|
DPP-IV-IN-2 (H-Lys(4-nitro-Z)-pyrrolidide) is an inhibitor of both DP8/9 and dipeptidyl peptidase IV (IC50s: 0.1 and 0.95 μM).
|
TN1418 |
Azaleatin
|
529-51-1
|
98.62%
|
|
Azaleatin is a natural product from Rhododendron simsii. Azaleatin is a dipeptidyl peptidase-IV inhibitor. Azaleatin can be used for type-2 diabetes and obesity ...
|
T1502 |
Vildagliptin
|
274901-16-5
|
98%
|
|
Vildagliptin (LAF237) is a cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Vildagliptin's cy...
|
T6999 |
Teneligliptin hydrobromide
|
906093-29-6
|
100%
|
|
Teneligliptin hydrobromide (MP-513 (hydrobromide)) is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, r...
|